Altogether, this study successfully excavated key metabolites that may be involved in the neurodevelopmental impairments caused by UTX deficiency, contributing to further elucidation of the pathological process of neurodevelopmental and cognitive disorders, as well as providing potential candidate targets for early intervention or prevention of neurodevelopmental diseases. This evidence concerns the gene KDM6A and cognitive disorder.